NEW YORK and VIENNA, Austria, April 14, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, the “Company”), a company…
BEDFORD, Mass., April 14, 2023 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development,…
PETACH TIKVA, Israel, April 14, 2023 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming…
PLEASANTON, Calif., April 14, 2023 (GLOBE NEWSWIRE) -- InkSpace Imaging is pleased to announce the appointment of George Rehm, JD,…
KANSAS CITY, Kan., April 14, 2023 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision…
Regulated Information Leuven, BELGIUM, Boston, MA, US – April 14, 2023 – 7.00 PM CET Oxurion NV (Euronext Brussels: OXUR)…
ISS, an independent, third-party proxy advisory firm, recommends Sernova’s shareholders vote FOR all management’s director nominees using ONLY management’s WHITE…
PetVivo Holdings, Inc. Spencer Breithaupt Joins PetVivo Holdings, Inc.MINNEAPOLIS, MN, US, April 14, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc.…
Disclosure of Share Capital and Voting Rights Outstanding as of March 31, 2023 (Pursuant to Article L.233-8 II of the…
- Data highlight favorable preclinical profiles for two chemically-distinct allosteric, oral small molecule KRAS inhibitors with potent anti-tumor activity -…